N

North Texas Endocrine Center | Dallas, TX

Research site
(Unclaimed)
Location
9301 N. Central Expressway Tower 2, Suite 570, Dallas, Texas, United States of America
Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Trials

10 of 24
Status: Active
Trial type: Interventional
Funder type: Industry

Filters
3
A Research Study Comparing How Well Different Doses of the Medicine NN0519-0130 Help People With Excess Body Weight Lose Weight

This study will look at how a new medicine called NNC0519-0130 helps people with excess body weight lose weight. The study will test up to 6 differen...

Not yet enrolling
Obesity
Drug: NNC0519-0130
Drug: Tirzepatide

This study will look at how well CagriSema helps people with type 2 diabetes lower their blood sugar and body weight. CagriSema is a new investigatio...

Enrolling
Type 2 Diabetes
Drug: Tirzepatide
Drug: Cagrilintide

The study will look at how well CagriSema helps people lower their blood sugar and body weight. CagriSema is a new weekly medicine that combines two...

Enrolling
Type 2 Diabetes Mellitus
Drug: Cagrilintide
Drug: Semaglutide

This study will look at how well the new medicine CagriSema helps people living with excess body weight and type 2 diabetes losing weight. Participan...

Active, not recruiting
Overweight
Type 2 Diabetes Mellitus
Drug: Cagrilintide
Drug: Placebo cagrilintide

This study will compare the new medicine IcoSema, which is a combination of insulin icodec and semaglutide, taken once a week, to insulin glargine (m...

Enrolling
Type 2 Diabetes
Drug: Insulin glargine
Drug: IcoSema

The main purpose of this study is to measure the safety and efficacy of insulin efsitora alfa (LY3209590) compared with insulin degludec in participa...

Active, not recruiting
Diabetes
Type 1 Diabetes
Drug: Insulin Degludec
Drug: Insulin Efsitora Alfa

The purpose of the trial is to assess the efficacy and safety of tirzepatide to dulaglutide in participants with type 2 diabetes and increased cardio...

Active, not recruiting
Type 2 Diabetes Mellitus
Drug: Tirzepatide
Drug: Dulaglutide

This is a study of tirzepatide in participants with overweight and obesity. The main purpose is to learn more about how tirzepatide affects body weig...

Active, not recruiting
Overweight
Obesity
Drug: Tirzepatide
Drug: Placebo

The main purpose of this phase 3b study is to evaluate the efficacy and safety of tirzepatide compared with semaglutide in adult participants who hav...

Active, not recruiting
Overweight
Obesity
Drug: Tirzepatide
Drug: Semaglutide

The study is designed to assess the efficacy, safety, tolerability, and transformation within the human body of INV-202 investigational drug in the t...

Enrolling
Diabetic Kidney Disease
Drug: Placebo
Drug: INV-202

Trial conditions

Diabetes Mellitus (16 trials)
Type 2 Diabetes Mellitus (11 trials)
Obesity (5 trials)
Overweight (4 trials)
Type 1 Diabetes Mellitus (3 trials)
Diabetic Nephropathies (2 trials)
Kidney Diseases (2 trials)
Renal Insufficiency (2 trials)
Autoimmune Thyroiditis (1 trial)
Diabetic Neuropathies (1 trial)

And 4 more

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems